In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya

Tropical Medicine and International Health

Volumn 14, Issue 3, 2009, Pages 294-300

  Thwing, J I ^a   Odero, C O ^b   Odhiambo, F O ^b   Otieno, K O ^b   Kariuki, S ^b   Ord, R ^c   Roper, C ^c   McMorrow, M ^a   Vulule, J ^b   Slutsker, L ^a   Newman, R D ^a   Hamel, M J ^a,b   Desai, M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Amodiaquine artesunate; Artemether lumefantrine; Chloroquine; Clinical trial; Kenya; Malaria; Resistance

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLOROQUINE;

DISEASE TREATMENT; DRUG; DRUG RESISTANCE; MALARIA; PARASITOLOGY; POLYMERASE CHAIN REACTION; PROTOZOAN; RISK FACTOR;

ARTICLE; AXILLA TEMPERATURE; BLOOD SMEAR; BODY WEIGHT; CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GENE; HUMAN; IN VIVO STUDY; INFECTION RISK; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RECURRENT INFECTION; REINFECTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VOMITING;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS; RECURRENCE; TREATMENT OUTCOME;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 60349097027     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2009.02222.x     Document Type: Article

References (21)

1. Abacassamo F, Enosse S, Aponte JJ et al. (2004) Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. Tropical Medicine and International Health 9, 200 208.
2. Abuya TO, Mutemi W, Karisa B, Ochola SA, Fegan G Marsh V (2007) Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malaria Journal 6, e57.
3. Adjuik M, Agnamey P, Babiker A et al. (2002) Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359, 1365 1372.
4. Djimdé A, Doumbo OK, Cortese JF et al. (2001) A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine 344, 257 263.
5. Dorsey G, Staedke S, Clark TD et al. (2007) Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. The Journal of the American Medical Association 297, 2210 2219.
6. Hamel MJ, Holtz T, Mkandala C et al. (2005) Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia. American Journal of Tropical Medicine and Hygiene 73, 609 615.
7. Happi CT, Gbotosho GO, Folarin OA et al. (2006) Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. American Journal of Tropical Medicine and Hygiene 75, 155 161.
8. Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO Björkman A (2006) Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infection Genetics Evolution 6, 309 314.
9. Holmgren G, Hamrin J, Svård J, Mårtensson A, Pedro Gil JP Björkman A (2007) Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infection Genetics Evolution 7, 562 569.
10. Humphreys GS, Merinopoulos I, Ahmed J et al. (2007) Amodiaquine and Artemether-Lumefantrine Select Distinct Alleles of the Plasmodium falciparum mdr1 Gene in Tanzanian Children Treated for Uncomplicated Malaria. Antimicrobial Agents and Chemotherapy 51, 991 997.
11. Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K Abdulla S (2007) Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malaria Journal 6, e146.
12. Mårtensson A, Strömberg J, Sisowath C et al. (2005) Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clinical Infectious Diseases 41, 1079 1086.
13. Mutabingwa TK, Anthony D, Heller A et al. (2005) Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365, 1474 1480.
14. Nsobya SL, Dokomajila C, Joloba M, Dorsey G Rosenthal PJ (2007) Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with artesunate-amodiaquine in Uganda. Antimicrobial Agents and Chemotherapy 51, 3023 3025.
15. Phillips I Wharton B (1968) Acute bacterial infection in kwashiorkor and marasmus. BMJ i, 407 409.
16. Rwagacondo CE, Karema C, Mugisha V et al. (2004) Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria. Tropical Medicine and International Health 9, 1091 1098.
17. Snounou G, Zhu X, Siripoon N et al. (1999) Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 369 374.
18. Sowunmi A, Balogun T, Gbotosho GO, Happi CT, Adedeji AA Fehintola FA (2007) Activities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in children. Antimicrobial Agents and Chemotherapy 51, 1694 1699.
19. Sutherland CJ, Haustein T, Gadalla N, Armstrong M, Doherty J Chiodini P (2007) Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. Journal of Antimicrobial Chemotherapy 59, 1197 1199.
20. Tinto H, Guekoun L, Zongo I, Guiguemdé RT, D'Alessandro U Ouédraogo JB (2008) Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso. Tropical Medicine and International Health 13, 238 240.
21. WHO (2005) Classification of Treatment Outcomes. Available at: http://www.malariadrugresistance.net/warn/clinical/files/ WHOClassificationofTreatmentOutcomes.pdf.